Quadrant Capital Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.89K Hold
159
﹤0.01% 2514
2025
Q4
$1.58K Hold
159
﹤0.01% 2551
2025
Q3
$1.42K Buy
+159
New +$1.47K ﹤0.01% 2522
2025
Q2
Sell
-159
Closed -$1.72K 1358
2025
Q1
$1.72K Hold
159
﹤0.01% 2534
2024
Q4
$1.51K Sell
159
-65
-29% -$658 ﹤0.01% 2537
2024
Q3
$2.52K Buy
224
+65
+41% +$691 ﹤0.01% 2456
2024
Q2
$1.59K Sell
159
-319
-67% -$3.24K ﹤0.01% 2509
2024
Q1
$5.5K Sell
478
-1,829
-79% -$15.5K ﹤0.01% 2284
2023
Q4
$16.8K Buy
2,307
+1,674
+264% +$13.2K ﹤0.01% 1889
2023
Q3
$5.76K Buy
633
+438
+225% +$5.25K ﹤0.01% 2137
2023
Q2
$2.37K Buy
195
+177
+983% +$1.97K ﹤0.01% 2378
2023
Q1
$224 Sell
18
-478
-96% -$8.79K ﹤0.01% 2669
2022
Q4
$9.53K Sell
496
-2
-0.4% -$42 ﹤0.01% 1969
2022
Q3
$9K Sell
498
-7,141
-93% -$147K ﹤0.01% 1912
2022
Q2
$138K Buy
7,639
+139
+2% +$2.26K 0.02% 529
2022
Q1
$120K Sell
7,500
-17
-0.2% -$306 0.01% 602
2021
Q4
$184K Buy
7,517
+17
+0.2% +$399 0.02% 463
2021
Q3
$175K Hold
7,500
0.02% 431
2021
Q2
$206K Buy
+7,500
New +$214K 0.03% 374

Other funds holding AHCO

Quadrant Capital Group's AHCO Position: Q1 2026 in Review

Quadrant Capital Group held its AdaptHealth (AHCO) position steady in Q1 2026 at 159 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2514.

Quadrant Capital Group first reported a position in AHCO in Q2 2021 and has held it in 19 quarters since. The position peaked at $206K in Q2 2021. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Quadrant Capital Group held 159 shares of AdaptHealth worth $1.89K as of Q1 2026.
  • Quadrant Capital Group left its AdaptHealth share count unchanged in Q1 2026.
  • AdaptHealth made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2514 holding.
  • Quadrant Capital Group first reported a position in AdaptHealth in Q2 2021 and has held it in 19 quarters since.
  • Quadrant Capital Group's AdaptHealth position peaked at $206K in Q2 2021.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.